AKT and heart remodelling: too much of a good thing?: Editorial

This editorial refers to ‘Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases-nuclear factor κB pathway in cardiomyocytes’, by M. Wang et al., https://doi.org/10.1093/eurheartj/ehaf349.It has long been established that the ser...

Full description

Saved in:
Bibliographic Details
Main Authors: Wardman, Rhys (Author) , Heineke, Jörg (Author)
Format: Article (Journal) Editorial
Language:English
Published: 05 August 2025
In: European heart journal
Year: 2025, Pages: 1-3
ISSN:1522-9645
DOI:10.1093/eurheartj/ehaf506
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehaf506
Get full text
Author Notes:Rhys Wardman and Joerg Heineke

MARC

LEADER 00000caa a22000002c 4500
001 1939887208
003 DE-627
005 20251104111409.0
007 cr uuu---uuuuu
008 251103s2025 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehaf506  |2 doi 
035 |a (DE-627)1939887208 
035 |a (DE-599)KXP1939887208 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wardman, Rhys  |e VerfasserIn  |0 (DE-588)131132464X  |0 (DE-627)1871299470  |4 aut 
245 1 0 |a AKT and heart remodelling: too much of a good thing?  |b Editorial  |c Rhys Wardman and Joerg Heineke 
264 1 |c 05 August 2025 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.11.2025 
520 |a This editorial refers to ‘Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases-nuclear factor κB pathway in cardiomyocytes’, by M. Wang et al., https://doi.org/10.1093/eurheartj/ehaf349.It has long been established that the serine/threonine kinase AKT plays a central role in physiological and pathophysiological signalling responses in the heart. As a key downstream node of phosphoinositide 3-kinase (PI3K), AKT relays extracellular signalling cues in order to coordinate metabolic and structural rearrangements widely thought to have beneficial effects on the heart.1 Indeed, AKT has been classically seen as a cardio-protective molecule by promoting cardiomyocyte survival and function, regulating key processes such as hypertrophy, angiogenesis, and stress adaptation in order to promote physiological growth whilst preventing pathological hypertrophy and cardiac dysfunction.1,2 For example, previous work has shown that transient activation of AKT enhances myocardial contractility and may delay the progression of heart failure, as well as inhibiting cardiomyocyte death by inhibiting proapoptotic factors such as BAD and caspase-9, preserving cardiomyocyte function following transient ischaemia. Moreover, AKT-driven substrate phosphorylation in cardiomyocytes promotes angiogenesis by increasing vascular endothelial growth factor A (VEGF-A) and Angiopoietin 2 levels to maintain myocardial vascular density.3-6 
700 1 |a Heineke, Jörg  |d 1974-  |e VerfasserIn  |0 (DE-588)122672321  |0 (DE-627)082082715  |0 (DE-576)293374805  |4 aut 
773 0 8 |i Enthalten in  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g (2025), Artikel-ID ehaf506, Seite 1-3  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a AKT and heart remodelling: too much of a good thing? Editorial 
773 1 8 |g year:2025  |g elocationid:ehaf506  |g pages:1-3  |g extent:3  |a AKT and heart remodelling: too much of a good thing? Editorial 
787 0 8 |i Ergänzung zu  |a Wang, M. et al.  |t Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases–nuclear factor κB pathway in cardiomyocytes, in: European Heart Journal  |d 2025  |g 2025, Artikelnummer ehaf349, Seite 1-16  |o 10.1093/eurheartj/ehaf349 
856 4 0 |u https://doi.org/10.1093/eurheartj/ehaf506  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251103 
993 |a Editorial 
994 |a 2025 
998 |g 122672321  |a Heineke, Jörg  |m 122672321:Heineke, Jörg  |d 60000  |d 65000  |e 60000PH122672321  |e 65000PH122672321  |k 0/60000/  |k 1/60000/65000/  |p 2  |y j 
998 |g 131132464X  |a Wardman, Rhys  |m 131132464X:Wardman, Rhys  |d 60000  |d 65000  |e 60000PW131132464X  |e 65000PW131132464X  |k 0/60000/  |k 1/60000/65000/  |p 1  |x j 
999 |a KXP-PPN1939887208  |e 479558799X 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"05 August 2025"}],"language":["eng"],"title":[{"subtitle":"Editorial","title":"AKT and heart remodelling: too much of a good thing?","title_sort":"AKT and heart remodelling: too much of a good thing?"}],"recId":"1939887208","person":[{"display":"Wardman, Rhys","family":"Wardman","given":"Rhys","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Heineke, Jörg","family":"Heineke","given":"Jörg"}],"relHost":[{"pubHistory":["1.1980 -"],"origin":[{"publisher":"Oxford University Press ; Harcourt","dateIssuedDisp":"1980-","publisherPlace":"Oxford ; London [u.a.]","dateIssuedKey":"1980"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"European heart journal","title_sort":"European heart journal"}],"note":["Gesehen am 12.09.2017"],"part":{"extent":"3","text":"(2025), Artikel-ID ehaf506, Seite 1-3","year":"2025","pages":"1-3"},"recId":"320415813","disp":"AKT and heart remodelling: too much of a good thing? EditorialEuropean heart journal","id":{"eki":["320415813"],"issn":["1522-9645"],"zdb":["2001908-7"]},"type":{"bibl":"periodical","media":"Online-Ressource"}}],"name":{"displayForm":["Rhys Wardman and Joerg Heineke"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"3 S."}],"note":["Gesehen am 03.11.2025"],"id":{"eki":["1939887208"],"doi":["10.1093/eurheartj/ehaf506"]}} 
SRT |a WARDMANRHYAKTANDHEAR0520